LFST icon

Lifestance Health

6.09 USD
-0.07
1.14%
Updated Apr 22, 2:52 PM EDT
1 day
-1.14%
5 days
-11.48%
1 month
-9.91%
3 months
-23.59%
6 months
-16.23%
Year to date
-19.34%
1 year
3.75%
5 years
-72.19%
10 years
-72.19%
 

About: LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.

Employees: 10,218

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

474% more call options, than puts

Call options by funds: $44.7M | Put options by funds: $7.77M

171% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 14

79% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 34

18% more funds holding

Funds holding: 130 [Q3] → 153 (+23) [Q4]

8% more capital invested

Capital invested by funds: $2.3B [Q3] → $2.48B (+$178M) [Q4]

1.99% more ownership

Funds ownership: 85.98% [Q3] → 87.98% (+1.99%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$8
31%
upside
Avg. target
$8.50
40%
upside
High target
$9
48%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Keybanc
Steve Dechert
100% 1-year accuracy
1 / 1 met price target
48%upside
$9
Overweight
Initiated
8 Apr 2025
Canaccord Genuity
Richard Close
32% 1-year accuracy
8 / 25 met price target
31%upside
$8
Buy
Initiated
3 Apr 2025

Financial journalist opinion

Based on 3 articles about LFST published over the past 30 days

Positive
Seeking Alpha
8 hours ago
LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion
I remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and digital check-in tool enhance clinician retention and patient accessibility, driving sustainable growth and competitive advantage. LFST's adjusted EBITDA margin reached 10.1% in 4Q24, with management targeting 15-20% over time, supported by operational efficiencies and higher-margin services.
LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion
Neutral
GlobeNewsWire
22 hours ago
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025.
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
Positive
Zacks Investment Research
1 week ago
LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains?
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains?
Negative
Zacks Investment Research
1 month ago
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Neutral
Seeking Alpha
1 month ago
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrea Alfonso - UBS Operator Thank you for standing by. My name is Danielle, and I will be your conference operator today.
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago.
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
Neutral
PRNewsWire
1 month ago
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer.
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
Neutral
GlobeNewsWire
1 month ago
LifeStance Reports Fourth Quarter and Full Year 2024 Results
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024.
LifeStance Reports Fourth Quarter and Full Year 2024 Results
Negative
Zacks Investment Research
2 months ago
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Neutral
GlobeNewsWire
2 months ago
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025.
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
Charts implemented using Lightweight Charts™